• biliary atresia market to expand significantly by 2034, states delveinsight report | albireo pharma, mirum pharmaceuticals Barchart Wed, 22 Jan 2025 16:31:57 GMT
• constipation clinical trials 2024: fda approvals, medication, openPR Fri, 25 Oct 2024 07:00:00 GMT
• alagille syndrome market forecasted to surge in coming years, openPR Thu, 03 Oct 2024 22:02:00 GMT
• albireo pharmaceuticals | biotechnology | the pharmaletter The Pharma Letter Tue, 09 Jul 2024 03:27:03 GMT
• albireo pharma, inc. (nasdaq:albo): when will it breakeven? Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• wall street analysts predict an 184% upside in albireo pharma (albo): here's what you should know Yahoo News UK Fri, 21 Jun 2024 16:34:28 GMT
• albo - albireo reports second quarter 2019 financial results br.ADVFN.com Fri, 14 Jun 2024 13:33:29 GMT
• genfit gets accelerated approval for new rare liver disease drug The Pharma Letter Tue, 11 Jun 2024 07:00:00 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Wed, 29 May 2024 10:41:18 GMT
• albireo pharma (albo) reports q4 loss, tops revenue estimates Yahoo News Australia Wed, 29 May 2024 04:25:00 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Sun, 26 May 2024 12:46:33 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Sat, 25 May 2024 11:41:56 GMT
• did albireo pharma's (nasdaq:albo) share price deserve to gain 81%? Yahoo Movies Canada Wed, 22 May 2024 00:11:16 GMT
• albireo pharma (albo) reports q4 loss, tops revenue estimates Yahoo News Australia Sat, 18 May 2024 03:32:00 GMT
• is a surprise coming for albireo pharma (albo) this earnings season? Yahoo Singapore News Mon, 06 May 2024 14:41:00 GMT
• albireo pharma (albo) soars 14.4%: is further upside left in the stock? Yahoo Movies UK Mon, 06 May 2024 07:09:12 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Sun, 05 May 2024 13:57:11 GMT
• albireo pharma (albo) soars 14.4%: is further upside left in the stock? Yahoo Movies UK Fri, 03 May 2024 14:11:22 GMT
• albireo (albo) gets fda nod for rare liver disease drug Yahoo Movies UK Mon, 29 Apr 2024 16:53:48 GMT
• albireo (albo) gets fda nod for rare liver disease drug Yahoo Movies UK Sat, 27 Apr 2024 16:53:48 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Mon, 22 Apr 2024 11:37:52 GMT
• ileal sodium & bile acid cotransporter market rapid growth at deep value price :albireo pharma inc, cj healthcare ... Post Production Buyers Guide Wed, 17 Apr 2024 08:07:29 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Tue, 16 Apr 2024 14:07:22 GMT
• Mirum scores 2nd FDA nod for rare liver disease drug Livmarli, this one to treat PFIC Fierce Pharma Wed, 13 Mar 2024 07:00:00 GMT
• mirum expands label for rare liver disease drug, serving up more competition for ipsen's bylvay Endpoints News Wed, 13 Mar 2024 07:00:00 GMT
• biliary atresia market to register incremental growth during the forecast period (2023-2032), asserts delveinsight | albireo pharm... The Globe and Mail Tue, 12 Mar 2024 07:00:00 GMT
• biliary atresia market | cagr, emerging drugs, marketed therapies, key companies, and epidemiology A spasso con Smith Thu, 29 Feb 2024 10:40:26 GMT
• alagille syndrome market size, share, growth, trends, forecast by 2024-2031 | albireo pharma, ipsen pharma, EIN News Wed, 17 Jan 2024 14:01:00 GMT
• chronic idiopathic constipation treatment market rapid growth at deep value price :bayer ag, albireo pharma, inc ... Artrocker Wed, 10 Jan 2024 13:02:19 GMT
• ileal sodium/bile acid cotransporter market report analysis, research studies |albireo pharma inc, cj healthcare ... Rough Cut Reviews Tue, 02 Jan 2024 04:59:03 GMT
• pruritus ani medicine market is expected to record the massive growth | abbvie (allergan plc), albireo pharma ... salisburyandstonehenge Wed, 13 Dec 2023 07:02:15 GMT
• pruritus type skin diseases medicine market to witness massive growth by 2030 | abbvie (allergan plc), albireo ... salisburyandstonehenge Wed, 13 Dec 2023 07:02:10 GMT
• ileal sodium/bile acid cotransporter market to expand with significant cagr by 2029 |albireo pharma inc, cj ... Artrocker Tue, 12 Dec 2023 10:39:18 GMT
• ileal sodium/bile acid cotransporter market will touch new level in upcoming year | albireo pharma inc, cj ... salisburyandstonehenge Fri, 01 Dec 2023 09:10:31 GMT
• pruritus ani medicine market developments 2029 |abbvie (allergan plc), albireo pharma, astellas pharma inc., cipla ... Argyle Report Tue, 21 Nov 2023 12:08:27 GMT
• countries ileal sodium/bile acid cotransporter industry scope – albireo pharma inc, cj health care corp ... Argyle Report Mon, 20 Nov 2023 04:49:36 GMT
• sindrome di alagille: l'ema nega la designazione orfana a odevixibat Osservatorio Malattie Rare Sat, 11 Nov 2023 08:00:00 GMT
• odevixibat safe for alagille syndrome based on hepatic changes AJMC.com Managed Markets Network Wed, 08 Nov 2023 08:00:00 GMT
• ileal sodium/bile acid cotransporter market 2023: comprehensive study by top key players albireo pharma inc, cj ... Argyle Report Mon, 06 Nov 2023 17:39:34 GMT
• mbx biosciences announces appointment of michelle graham as chief human resources officer GlobeNewswire Wed, 01 Nov 2023 07:00:00 GMT
• primary sclerosing cholangitis market to grow at a tremendous ... PR Newswire Tue, 31 Oct 2023 07:00:00 GMT
• ipsen updates on e.u. marketing authorisation application for ... Ipsen Mon, 23 Oct 2023 06:43:40 GMT
• life biosciences grows up: a q&a with jerry mclaughlin Life Science Leader Magazine Mon, 02 Oct 2023 07:00:00 GMT
• ipsen announces change in r&d leadership: howard mayer to retire ... Ipsen Fri, 01 Sep 2023 07:00:00 GMT
• catalent announces governance enhancements and new ... Business Wire Tue, 29 Aug 2023 07:00:00 GMT
• amicus therapeutics appoints simon harford as chief financial ... GlobeNewswire Mon, 21 Aug 2023 07:00:00 GMT
• Bylvay (odevixibat) for the Treatment of Pruritus, USA Clinical Trials Arena Fri, 18 Aug 2023 07:00:00 GMT
• fda grants approval to ipsen for ultra-rare bone disease drug MM+M Online Thu, 17 Aug 2023 07:00:00 GMT
• orphan drugs market size to surpass usd 368.43 billion in 2030 ... Yahoo Finance Tue, 01 Aug 2023 07:00:00 GMT
• the galien foundation announces 2023 prix galien usa nominees ... PR Newswire Thu, 27 Jul 2023 07:00:00 GMT
• ipsen delivers solid h1 2023 results and upgrades its full-year ... Ipsen Thu, 27 Jul 2023 07:00:00 GMT
• mirum snaps up 2 liver disease drugs from travere for up to $445m FiercePharma Tue, 18 Jul 2023 07:00:00 GMT
• lessons learned from the intense back-and-forth over a $1b acquisition Timmerman Report Mon, 10 Jul 2023 07:00:00 GMT
• as-0369 effectively prevents cholemic nephropathy in models BioWorld Online Mon, 03 Jul 2023 07:00:00 GMT
• seven things life sciences buyers and sellers should know about ... Sidley Austin LLP Thu, 29 Jun 2023 07:00:00 GMT
• global constipation treatment market report 2023-2030 - lucrative ... Yahoo Finance Fri, 23 Jun 2023 07:00:00 GMT
• Key Components and Trends of CVRs in Life Sciences Public M&A Deals The Harvard Law School Forum on Corporate Governance Fri, 16 Jun 2023 07:00:00 GMT
• bylvay backers buoyed as new nod brings relief for chronic illness The Pharma Letter Wed, 14 Jun 2023 07:00:00 GMT
• After Albireo buyout, Ipsen's Bylvay picks up new FDA-approved use Fierce Pharma Tue, 13 Jun 2023 07:00:00 GMT
• ipsen itching drug scratches off a second fda approval in rare ... MedCity News Tue, 13 Jun 2023 07:00:00 GMT
• metabolic dysfunction-associated fatty liver disease in people living ... Nature.com Tue, 06 Jun 2023 07:00:00 GMT
• go or no go? key fda decisions for argenx and regeneron Evaluate Pharma Wed, 31 May 2023 07:00:00 GMT
• risk stratified monitoring for methotrexate toxicity in immune ... The BMJ Tue, 30 May 2023 07:00:00 GMT
• anatomy of a cvr: a primer on the key components and trends of ... Sidley Austin LLP Fri, 19 May 2023 07:00:00 GMT
• regulatory tracker: ucb's zilbrysq picks up eu nod to treat ... FiercePharma Wed, 17 May 2023 15:16:51 GMT
• regulatory tracker: amid glp-1 probe, eu asks companies for more ... FiercePharma Wed, 17 May 2023 15:16:51 GMT
• ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Ipsen Thu, 27 Apr 2023 07:00:00 GMT
• law firm covington opens boston office, chasing life sciences work Reuters Tue, 18 Apr 2023 07:00:00 GMT
• ocelot bio appoints lise kjems, m.d., ph.d., as chief medical officer Business Wire Tue, 18 Apr 2023 07:00:00 GMT
• pfizer's fortunes overshadow first-quarter dealmaking Evaluate Pharma Tue, 11 Apr 2023 07:00:00 GMT
• a proteo-transcriptomic map of non-alcoholic fatty liver disease ... Nature.com Mon, 10 Apr 2023 07:00:00 GMT
• ipsen hunts for targets with $4.4 billion to spend, ceo says Bloomberg Thu, 06 Apr 2023 07:00:00 GMT
• rare disease player bridgebio draws buyout interest: report FiercePharma Tue, 28 Mar 2023 07:00:00 GMT
• biomarkers for staging fibrosis and non-alcoholic steatohepatitis in ... The Lancet Mon, 20 Mar 2023 07:00:00 GMT
• semaglutide 2·4 mg once weekly in patients with non-alcoholic ... The Lancet Thu, 16 Mar 2023 07:00:00 GMT
• Ipsen concludes purchase of Albireo Pharma Pharmaceutical Technology Fri, 03 Mar 2023 08:00:00 GMT
• ipsen réussit son opa sur albireo et étend son portefeuille en ... Investir Fri, 03 Mar 2023 08:00:00 GMT
• ipsen completes acquisition of albireo, expanding the scope of its rare disease portfolio Ipsen Thu, 02 Mar 2023 08:00:00 GMT
• bristol myers dodges one $6.4b celgene buyout cvr suit, but the battle is far from over FiercePharma Thu, 02 Mar 2023 08:00:00 GMT
• is albireo pharma (albo) stock outpacing its medical peers this year? Yahoo Singapore News Wed, 01 Mar 2023 08:00:00 GMT
• ipsen extends expiration date of tender offer for albireo pharma, inc. to 1 march 2023 Ipsen Wed, 22 Feb 2023 06:17:54 GMT
• fda grants june 15, 2023 pdufa date to albireo for bylvay® in alagille syndrome GlobeNewswire Tue, 14 Feb 2023 08:00:00 GMT
• biotech went through its ipo boom. now the shakeout is underway Bloomberg Mon, 13 Feb 2023 08:00:00 GMT
• business development remains top priority for ipsen insights.citeline.com Fri, 10 Feb 2023 08:00:00 GMT
• strong full-year 2022 results and guidance for 2023 | ipsen global Ipsen Thu, 09 Feb 2023 08:00:00 GMT
• buyout from ipsen: do not underestimate the value of albireo's contingent value right Seeking Alpha Thu, 02 Feb 2023 08:00:00 GMT
• buyout from ipsen: do not underestimate value of albireo's contingent value right Seeking Alpha Thu, 02 Feb 2023 08:00:00 GMT
• ey eyes comeback for biopharma m&a Genetic Engineering & Biotechnology News Tue, 31 Jan 2023 08:00:00 GMT
• ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price a... Business Wire Tue, 24 Jan 2023 08:00:00 GMT
• How a buyer's sudden withdrawal gave Ipsen a chance to fight for Albireo Fierce Pharma Tue, 24 Jan 2023 08:00:00 GMT
• Failed deal, bidding war paved the way for Ipsen’s $952M rare disease buyout Endpoints News Tue, 24 Jan 2023 08:00:00 GMT
• how a sudden withdrawal led to m&a bidding war for albireo FiercePharma Tue, 24 Jan 2023 08:00:00 GMT
• cincor, albireo each received higher bids in 2022 before this month's m&a deals BioCentury Tue, 24 Jan 2023 08:00:00 GMT
• can the fda keep the momentum going for rare disease drug approvals? Pharmaceutical Technology Mon, 23 Jan 2023 08:00:00 GMT
• primary biliary cirrhosis clinical trial pipeline insights featuring 22 ... GlobeNewswire Mon, 23 Jan 2023 08:00:00 GMT
• ipsen's onivyde turns in positive results in pancreatic cancer FiercePharma Fri, 20 Jan 2023 08:00:00 GMT
• jpm23: ipsen ceo happy to take on big pharma in rare diseases but says gene therapy is rife with risk FiercePharma Wed, 18 Jan 2023 08:00:00 GMT
• ipsen ceo steers clear of gene therapy despite rare disease push FiercePharma Wed, 18 Jan 2023 08:00:00 GMT
• stock watch: j.p. morgan conference, big splash news and stock prices Scrip Mon, 16 Jan 2023 08:00:00 GMT
• tanking biotech stocks will mean a big year for deals. who could benefit. Barron's Sat, 14 Jan 2023 08:00:00 GMT
• StockWatch: Shares Double for Targets of 3 Buyout Deals Announced at JPM Genetic Engineering and Biotechnology News Fri, 13 Jan 2023 08:00:00 GMT
• ipsen to acquire rare disease specialist albireo in deal worth over $950m PMLiVE Fri, 13 Jan 2023 08:00:00 GMT
• albireo pharma stock: elucidating the ipsen buyout (rating upgrade) (nasdaq:albo) Seeking Alpha Tue, 10 Jan 2023 08:00:00 GMT
• albireo pharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price a... Business Wire Tue, 10 Jan 2023 08:00:00 GMT
• JPM23: Ipsen scoops up liver disease specialist Albireo for $952M Fierce Pharma Mon, 09 Jan 2023 08:00:00 GMT
• Orrick Advises Ipsen on Acquisition of Liver Disease Treatment Innovator Albireo orrick.com Mon, 09 Jan 2023 08:00:00 GMT
• Twin biggies rattle JPM takeover field: AZ signs $1.8B deal with Cincor, Chiesi to buy Amryt; Ipsen snatches up Albireo, too BioWorld MedTech Mon, 09 Jan 2023 08:00:00 GMT
• In separate deals, European drug makers buying local biotech firms CinCor and Albireo The Boston Globe Mon, 09 Jan 2023 08:00:00 GMT
• france-based ipsen acquires albireo pharma enriching its rare disease portfolio, pipeline Yahoo Finance Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to acquire albireo accelerating growth in rare disease with treatments for several pediatric liver diseases Business Wire Mon, 09 Jan 2023 08:00:00 GMT
• at #jpm23, another rare disease buyout as ipsen acquires albireo for $952m Endpoints News Mon, 09 Jan 2023 08:00:00 GMT
• billion dollar buy adds albireo to ipsen's list of strategic takeovers The Pharma Letter Mon, 09 Jan 2023 08:00:00 GMT
• cvrs address risks in billion-dollar az-cincor, ipsen-albireo deals BioCentury Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to buy liver disease drugmaker for $952m The Business Journals Mon, 09 Jan 2023 08:00:00 GMT
• m&a monday: astrazeneca leads way as 3 pharmas splash out $3.5b in deals MedCity News Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to acquire albireo - growth in rare disease | ipsen global Ipsen Mon, 09 Jan 2023 08:00:00 GMT
• ipsen pays $952m to acquire albireo and liver disease med bylvay FiercePharma Mon, 09 Jan 2023 08:00:00 GMT
• shareholder alert: ademi llp investigates whether albireo pharma, inc. has obtained a fair price in its transaction with ... Marketscreener.com Mon, 09 Jan 2023 08:00:00 GMT
• s&p 500 gains 0.6%; albireo pharma shares spike higher Markets Insider Mon, 09 Jan 2023 08:00:00 GMT
• alert: the m&a class action firm announces the investigation of albireo pharma, inc. - albo PR Newswire Mon, 09 Jan 2023 08:00:00 GMT
• u.s. stocks mixed at close of trade; dow jones industrial average down 0.34% by investing.com Investing.com Mon, 09 Jan 2023 08:00:00 GMT
• biotechs cincor, albireo jump on takeovers by larger drugmakers Bloomberg Mon, 09 Jan 2023 08:00:00 GMT
• jp morgan 2023 – day one sees buyers make the most of straitened times Evaluate Pharma Mon, 09 Jan 2023 08:00:00 GMT
• tesla, zillow, regeneron, macy's, and more stock market movers Barron's Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to buy liver disease drugmaker for $952m - boston business journal The Business Journals Mon, 09 Jan 2023 08:00:00 GMT
• 2 tiny nasdaq stocks making major merger moves monday The Motley Fool Mon, 09 Jan 2023 08:00:00 GMT
• astrazeneca boosts heart, kidney business with $1.8 bln cincor deal Reuters Mon, 09 Jan 2023 08:00:00 GMT
• italian privately held chiesi farmaceutici to acquire amryt pharma ... Yahoo Finance Mon, 09 Jan 2023 08:00:00 GMT
• malattie epatiche, ipsen acquisisce albireo per un totale aggregato ... AboutPharma Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to acquire albireo accelerating growth in rare disease with treatments for several pediatric liver diseases Business Wire Sun, 08 Jan 2023 08:00:00 GMT
• madrigal sees road to approval for nash drug resmetirom pharmaphorum Tue, 20 Dec 2022 08:00:00 GMT
• albireo reports inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Tue, 06 Dec 2022 08:00:00 GMT
• albireo appoints paul streck, m.d., as chief medical officer & craig hopkinson, m.d., to board of directors GlobeNewswire Tue, 06 Dec 2022 08:00:00 GMT
• albireo pharma, inc. (albo) q3 2022 earnings call transcript Seeking Alpha Tue, 08 Nov 2022 08:00:00 GMT
• video: bylvay improves pruritus, reduces serum bile acids in ... Healio Mon, 07 Nov 2022 08:00:00 GMT
• albireo completes phase 3 bold study enrollment of bylvay(r) in biliary atresia GlobeNewswire Wed, 02 Nov 2022 07:00:00 GMT
• harnessing patient-centered science to improve health outcomes and commercial pharma success Applied Clinical Trials Online Tue, 01 Nov 2022 07:00:00 GMT
• the pharma letter podcast — episode 18 — focus on rare liver diseases, with albireo ceo ron cooper The Pharma Letter Mon, 31 Oct 2022 07:00:00 GMT
• analysts estimate albireo pharma (albo) to report a decline in earnings: what to look out for Yahoo Movies Canada Thu, 27 Oct 2022 07:00:00 GMT
• analysts expect mirum pharma's liver disease candidate might exceed rival product's penetration Yahoo Finance Tue, 25 Oct 2022 07:00:00 GMT
• Mirum gains an edge over rival Albireo in pediatric liver disease thanks to a higher dose Fierce Pharma Mon, 24 Oct 2022 07:00:00 GMT
• mirum gets a leg up on albireo in pediatric liver disease FiercePharma Mon, 24 Oct 2022 07:00:00 GMT
• atara's first-in-class allogeneic t-cell therapy nears eu nod FiercePharma Fri, 14 Oct 2022 07:00:00 GMT
• Albireo shares rocket as study sets up second Bylvay approval The Pharma Letter Wed, 12 Oct 2022 07:00:00 GMT
• albireo to participate in h.c. wainwright 3rd annual hepatitis b virus (hbv) conference GlobeNewswire Wed, 12 Oct 2022 07:00:00 GMT
• albireo (albo) up on results from alagille syndrome study Yahoo Finance Wed, 12 Oct 2022 07:00:00 GMT
• albireo: strong phase 3 data foretells more upside (nasdaq:albo) Seeking Alpha Wed, 12 Oct 2022 07:00:00 GMT
• albireo pharma (albo) soars 14.4%: is further upside left in the stock? Yahoo Movies Canada Wed, 12 Oct 2022 07:00:00 GMT
• Albireo's Bylvay aces test in Alagille syndrome, setting it up for 2nd pediatric liver disease nod Fierce Pharma Tue, 11 Oct 2022 07:00:00 GMT
• albireo pharma achieves positive phase 3 top-line results of bylvay in alagille syndrome Seeking Alpha Tue, 11 Oct 2022 07:00:00 GMT
• albireo touts phase iii success for bylvay in alagille syndrome FirstWord Pharma Tue, 11 Oct 2022 07:00:00 GMT
• albireo reports positive topline data from phase 3 trial of bylvay® (odevixibat) in alagille syndrome GlobeNewswire Tue, 11 Oct 2022 07:00:00 GMT
• albireo drug makes "profound" difference in rare alagille syndrome BioSpace Tue, 11 Oct 2022 07:00:00 GMT
• albireo to showcase new data at aasld the liver meeting® 2022 GlobeNewswire Wed, 05 Oct 2022 07:00:00 GMT
• money on the move: eagle, elucidata, prime medicine and more BioSpace Wed, 28 Sep 2022 07:00:00 GMT
• albireo pharma (albo) stock jumps 11%: will it continue to soar? Yahoo Finance Fri, 23 Sep 2022 07:00:00 GMT
• albireo announces $115 million royalty monetization agreement with sagard GlobeNewswire Thu, 22 Sep 2022 07:00:00 GMT
• albireo pharma (nasdaq: albo) shoots up post agreement with sagard - tipranks.com TipRanks Thu, 22 Sep 2022 07:00:00 GMT
• overcoming 4 challenges in orphan disease clinical trials Clinical Leader Thu, 22 Sep 2022 07:00:00 GMT
• albireo pharma, inc. (nasdaq:albo) analysts are reducing their forecasts for this year Nasdaq Tue, 23 Aug 2022 07:00:00 GMT
• albireo reports inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Mon, 22 Aug 2022 07:00:00 GMT
• albireo pharma inc (albo) stock falls -27.40% this week: is it a good pick? InvestorsObserver Mon, 22 Aug 2022 07:00:00 GMT
• time to worry? analysts are downgrading their albireo pharma, inc. (nasdaq:albo) outlook Yahoo Finance Sun, 21 Aug 2022 07:00:00 GMT
• Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat i... PR Newswire Tue, 16 Aug 2022 07:00:00 GMT
• albireo pharma stock slips ~26% after co cuts fy sales guidance for lead drug bylvay Seeking Alpha Tue, 16 Aug 2022 07:00:00 GMT
• is albireo pharma inc (albo) a leader in the biotechnology industry? InvestorsObserver Tue, 16 Aug 2022 07:00:00 GMT
• why albireo pharma (albo) shares are falling afterhours today Benzinga Mon, 15 Aug 2022 07:00:00 GMT
• is albireo pharma (albo) outperforming other medical stocks this year? Yahoo Lifestyle Singapore Thu, 11 Aug 2022 07:00:00 GMT
• albireo appoints habib dable and susan alesina to board of directors citybiz Wed, 10 Aug 2022 07:00:00 GMT
• the galien foundation announces 2022 prix galien usa nominees ... PR Newswire Tue, 26 Jul 2022 07:00:00 GMT
• odevixibat scratches the itch of kids' rare liver disease Medpage Today Fri, 08 Jul 2022 07:00:00 GMT
• biliary atresia treatment market to see booming growth 2022-2028 | astrazeneca plc, eisai co., ltd., mirum ... Digital Journal Tue, 05 Jul 2022 07:00:00 GMT
• Transitioning To Orphan Drug Commercialization: A Q&A With Albireo Pharma's CEO Ron Cooper Life Science Leader Fri, 01 Jul 2022 07:00:00 GMT
• Novartis buys FDA priority review voucher from bankrupt Mallinckrodt for $100M Fierce Pharma Fri, 01 Jul 2022 07:00:00 GMT
• novartis pays $100m for mallinckrodt's priority review voucher FiercePharma Fri, 01 Jul 2022 07:00:00 GMT
• albireo to present at the william blair biotech focus conference 2022 GlobeNewswire Thu, 30 Jun 2022 07:00:00 GMT
• odevixibat treatment in progressive familial intrahepatic cholestasis ... The Lancet Thu, 30 Jun 2022 07:00:00 GMT
• albireo reports inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Sun, 12 Jun 2022 07:00:00 GMT
• albireo pharma inc. (nasdaq: albo) shares data analyses from pedfic1 and pedfic2 studies evaluating bylvay BP Journal Mon, 06 Jun 2022 07:00:00 GMT
• albireo presented data in cholestatic liver diseases at digestive disease week (ddw) 2022 PharmiWeb.com Mon, 23 May 2022 07:00:00 GMT
• biliary atresia treatment market is estimated to be valued at us$ 1527.9 million by 2028 and is expected to exhibit a ... Medgadget Mon, 23 May 2022 07:00:00 GMT
• albireo pharma inc (albo) stock falls -29.05% this week: is it a good pick? InvestorsObserver Tue, 17 May 2022 07:00:00 GMT
• healthcare stocks on the move tuesday: bmea, rain, pear, rckt, pte, tnxp, albo, orgs InvestorsObserver Tue, 17 May 2022 07:00:00 GMT
• pm360 announces winners of the eighth annual elite awards PR Newswire Tue, 17 May 2022 07:00:00 GMT
• here's what albireo pharma, inc.'s (nasdaq:albo) shareholder ownership structure looks like Yahoo Finance Sun, 15 May 2022 07:00:00 GMT
• biotech stocks are having a terrible year. these 10 are still winning. Barron's Mon, 09 May 2022 07:00:00 GMT
• new resource for families struggling with pediatric liver disease PR Newswire Mon, 02 May 2022 07:00:00 GMT
• primary sclerosing cholangitis pipeline: therapeutic assessment ... GlobeNewswire Wed, 27 Apr 2022 07:00:00 GMT
• investing in albireo pharma (nasdaq:albo) five years ago would have delivered you a 57% gain Yahoo Finance UK Tue, 19 Apr 2022 07:00:00 GMT
• stock upgrades: albireo pharma shows rising relative strength Investor's Business Daily Thu, 07 Apr 2022 07:00:00 GMT
• 'No small feat': Albireo CEO talks biotech's commercial transition amid Bylvay launch Fierce Pharma Tue, 22 Mar 2022 07:00:00 GMT
• here's why albireo pharma (nasdaq:albo) can manage its debt despite losing money Yahoo Sport Australia Sat, 05 Mar 2022 08:00:00 GMT
• albireo reports q4 and year-end 2021 financial results and business update Yahoo Tue, 01 Mar 2022 08:00:00 GMT
• is albireo pharma inc (albo) stock worth a buy tuesday? InvestorsObserver Tue, 01 Mar 2022 08:00:00 GMT
• is a surprise coming for albireo pharma (albo) this earnings season? Yahoo Singapore News Mon, 28 Feb 2022 08:00:00 GMT
• nice recommends albireo’s bylvay®(odevixibat) for all pfic types PharmiWeb.com Tue, 22 Feb 2022 08:00:00 GMT
• nice backs nhs use of albireo’s bylvay for all pfic types The Pharma Letter Tue, 22 Feb 2022 08:00:00 GMT
• the zacks analyst blog highlights teladoc health, albireo pharma and the joint corp Yahoo Finance Tue, 22 Feb 2022 08:00:00 GMT
• nice backs nhs use of albireo's bylvay for all pfic types The Pharma Letter Tue, 22 Feb 2022 08:00:00 GMT
• nice recommends albireo's bylvay®(odevixibat) for all pfic types PharmiWeb.com Tue, 22 Feb 2022 08:00:00 GMT
• nice recommends albireo's bylvay® (odevixibat) for all pfic GlobeNewswire Tue, 22 Feb 2022 08:00:00 GMT
• albireo stock: global launches will further boost sales in 2022 (nasdaq:albo) Seeking Alpha Mon, 31 Jan 2022 08:00:00 GMT
• albireo increases 2021 bylvay™ (odevixibat) sales guidance GlobeNewswire Wed, 05 Jan 2022 08:00:00 GMT
• 2021 drug approvals: in a year dominated by covid, biopharma ... FiercePharma Tue, 04 Jan 2022 08:00:00 GMT
• albireo announces positive topline data from phase 1 study of a3907 GlobeNewswire Thu, 16 Dec 2021 08:00:00 GMT
• hemoshear therapeutics appoints patrick horn, md, phd, chief ... PR Newswire Tue, 14 Dec 2021 08:00:00 GMT
• Albireo CMO Horn is out the door 5 months after US, EU approvals of rare liver disease drug Fierce Biotech Thu, 09 Dec 2021 08:00:00 GMT
• albireo appoints constantine chinoporos as chief business officer citybiz Thu, 02 Dec 2021 08:00:00 GMT
Albireo Pharma, Inc(NASDAQ:ALBO) 
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...
Website: http://www.albireopharma.com
Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology